Good practice for introducing radiopharmaceuticals for clinical use.
"The use of new radiopharmaceuticals can provide extremely valuable information in the evaluation of cancer, as well as heart and brain diseases --- information that often times cannot be obtained by other means. However, there is a perceived need in many Member States for a useful reference to...
Clasificación: | Libro Electrónico |
---|---|
Autores Corporativos: | Asociación Latinoamericana de Sociedades de Biología y Medicina Nuclear (sponsoring body.), Asia Oceania Federation of Nuclear Medicine & Biology (sponsoring body.), European Association of Nuclear Medicine (sponsoring body.), Society of Nuclear Medicine and Molecular Imaging (sponsoring body.), World Federation of Nuclear Medicine and Biology (sponsoring body.) |
Formato: | Electrónico eBook |
Idioma: | Inglés |
Publicado: |
Vienna :
International Atomic Energy Agency,
2016.
|
Colección: | IAEA-TECDOC ;
1782. |
Temas: | |
Acceso en línea: | Texto completo |
Ejemplares similares
-
Alternative radionuclide production with a cyclotron.
Publicado: (2021) -
Cyclotron Produced Radionuclides.
por: IAEA
Publicado: (2016) -
Production, quality control and clinical applications of radiosynovectomy agents.
Publicado: (2021) -
Yttrium-90 and Rhenium-188 radiopharmaceuticals for radionuclide therapy.
Publicado: (2015) -
Progress in PET radiopharmaceuticals (quality control and theranostics) /
por: Sharma, Sushil K.
Publicado: (2016)